Natrecor for Pulmonary Hypertension in Lung Transplants

PHASE4CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Pulmonary Hypertension
Interventions
DRUG

Natrecor

Natrecor will be initiated as a bolus dose of 2 mcg/kg followed by a continuous infusion via infusion pump after induction of anesthesia but prior to incision. Natrecor infusion will be started at the recommended rate of 0.01mcg/kg/min. This dose may be adjusted by the investigator(s) only based on hemodynamic monitoring and pulmonary parameters. Study drug will be infused for a minimum of 24 hours and a maximum of 96 hours.

Trial Locations (1)

53792

University of Wisconsin Hospital and Clinics, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT00205426 - Natrecor for Pulmonary Hypertension in Lung Transplants | Biotech Hunter | Biotech Hunter